| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 4.58B | 4.57B | 4.77B | 4.50B | 4.13B |
| Gross Profit | 1.31B | 1.45B | 1.52B | 1.34B | 1.16B |
| EBITDA | 746.10M | 834.30M | 915.10M | 838.20M | 713.80M |
| Net Income | 288.40M | 352.70M | 394.10M | 407.40M | 369.10M |
Balance Sheet | |||||
| Total Assets | 6.68B | 6.41B | 6.54B | 5.77B | 5.17B |
| Cash, Cash Equivalents and Short-Term Investments | 386.50M | 389.50M | 450.90M | 379.90M | 314.80M |
| Total Debt | 2.16B | 2.26B | 2.58B | 2.12B | 1.65B |
| Total Liabilities | 3.33B | 3.43B | 3.84B | 3.42B | 2.79B |
| Stockholders Equity | 3.18B | 2.83B | 2.58B | 2.27B | 2.29B |
Cash Flow | |||||
| Free Cash Flow | 406.10M | 305.70M | 357.40M | 285.40M | 239.00M |
| Operating Cash Flow | 554.30M | 475.70M | 545.20M | 463.80M | 387.30M |
| Investing Cash Flow | -148.30M | -304.60M | -806.50M | -573.30M | -173.80M |
| Financing Cash Flow | -437.10M | -194.80M | 347.10M | 206.80M | -269.30M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | $17.44B | 64.85 | 8.66% | ― | 8.27% | 19.06% | |
78 Outperform | $19.95B | 20.03 | 17.96% | 2.52% | 0.24% | -1.85% | |
72 Outperform | $7.46B | 26.11 | 9.60% | 1.61% | -1.01% | -12.13% | |
72 Outperform | $15.90B | 31.01 | 37.22% | 1.22% | 3.27% | 10.89% | |
65 Neutral | $2.93B | 26.92 | 8.70% | 2.74% | -2.63% | -4.46% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | $13.91B | 33.95 | 4.52% | 4.42% | -1.40% | ― |
On February 13, 2026, Timken’s board approved a new share purchase plan effective March 1, 2026, authorizing the company to buy back up to 10 million of its outstanding common shares through open market purchases, privately negotiated transactions, or structured mechanisms such as accelerated share repurchases and Rule 10b5-1 plans. The program, which runs through February 28, 2031 and replaces a plan expiring February 28, 2026, signals the company’s ongoing capital-return strategy and may support earnings per share and shareholder value by reducing the share count over time.
The most recent analyst rating on (TKR) stock is a Buy with a $118.00 price target. To see the full list of analyst forecasts on Timken Company stock, see the TKR Stock Forecast page.
On February 13, 2026, Timken announced that James F. Palmer, chair of the Audit Committee and a member of the Compensation Committee, will retire from the board effective March 31, 2026, as part of a planned transition of the Audit Committee chair role to director Sarah C. Lauber. The company emphasized that Palmer’s retirement is not related to any financial or accounting issues or disagreements, framing the move as an orderly governance transition rather than a response to underlying controversy, which should reassure investors and other stakeholders about the stability of Timken’s oversight processes.
The most recent analyst rating on (TKR) stock is a Hold with a $108.00 price target. To see the full list of analyst forecasts on Timken Company stock, see the TKR Stock Forecast page.